vs
Side-by-side financial comparison of Dexcom (DXCM) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $766.5M, roughly 1.6× SCANSOURCE, INC.). Dexcom runs the higher net margin — 21.2% vs 2.2%, a 19.1% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 2.5%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 0.9%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
DXCM vs SCSC — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $766.5M |
| Net Profit | $267.3M | $16.5M |
| Gross Margin | 62.9% | 13.4% |
| Operating Margin | 25.6% | 2.3% |
| Net Margin | 21.2% | 2.2% |
| Revenue YoY | 21.6% | 2.5% |
| Net Profit YoY | 153.6% | -3.3% |
| EPS (diluted) | $0.67 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $766.5M | ||
| Q3 25 | $1.2B | $739.6M | ||
| Q2 25 | $1.2B | $812.9M | ||
| Q1 25 | $1.0B | $704.8M | ||
| Q4 24 | $1.1B | $747.5M | ||
| Q3 24 | $994.2M | $775.6M | ||
| Q2 24 | $1.0B | $746.1M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $16.5M | ||
| Q3 25 | $283.8M | $19.9M | ||
| Q2 25 | $179.8M | $20.1M | ||
| Q1 25 | $105.4M | $17.4M | ||
| Q4 24 | $151.7M | $17.1M | ||
| Q3 24 | $134.6M | $17.0M | ||
| Q2 24 | $143.5M | $16.1M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 13.4% | ||
| Q3 25 | 60.5% | 14.5% | ||
| Q2 25 | 59.5% | 12.9% | ||
| Q1 25 | 56.9% | 14.2% | ||
| Q4 24 | 58.9% | 13.6% | ||
| Q3 24 | 59.7% | 13.1% | ||
| Q2 24 | 62.4% | 13.0% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 2.3% | ||
| Q3 25 | 20.1% | 3.5% | ||
| Q2 25 | 18.4% | 3.3% | ||
| Q1 25 | 12.9% | 3.2% | ||
| Q4 24 | 17.0% | 2.5% | ||
| Q3 24 | 15.3% | 2.3% | ||
| Q2 24 | 15.7% | 2.9% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 2.2% | ||
| Q3 25 | 23.5% | 2.7% | ||
| Q2 25 | 15.5% | 2.5% | ||
| Q1 25 | 10.2% | 2.5% | ||
| Q4 24 | 13.6% | 2.3% | ||
| Q3 24 | 13.5% | 2.2% | ||
| Q2 24 | 14.3% | 2.2% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.75 | ||
| Q3 25 | $0.70 | $0.89 | ||
| Q2 25 | $0.45 | $0.87 | ||
| Q1 25 | $0.27 | $0.74 | ||
| Q4 24 | $0.37 | $0.70 | ||
| Q3 24 | $0.34 | $0.69 | ||
| Q2 24 | $0.35 | $0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $83.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $910.9M |
| Total Assets | $6.3B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $83.5M | ||
| Q3 25 | $1.8B | $124.9M | ||
| Q2 25 | $1.2B | $126.2M | ||
| Q1 25 | $904.9M | $146.3M | ||
| Q4 24 | $606.1M | $110.5M | ||
| Q3 24 | $621.2M | $145.0M | ||
| Q2 24 | $939.2M | $185.5M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $910.9M | ||
| Q3 25 | $2.7B | $914.0M | ||
| Q2 25 | $2.6B | $906.4M | ||
| Q1 25 | $2.3B | $901.7M | ||
| Q4 24 | $2.1B | $900.7M | ||
| Q3 24 | $2.0B | $920.9M | ||
| Q2 24 | $2.4B | $924.3M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $1.7B | ||
| Q3 25 | $7.5B | $1.7B | ||
| Q2 25 | $7.3B | $1.8B | ||
| Q1 25 | $6.8B | $1.7B | ||
| Q4 24 | $6.5B | $1.7B | ||
| Q3 24 | $6.4B | $1.8B | ||
| Q2 24 | $6.8B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $30.8M |
| Free Cash FlowOCF − Capex | — | $28.9M |
| FCF MarginFCF / Revenue | — | 3.8% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $30.8M | ||
| Q3 25 | $659.9M | $23.2M | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $183.8M | $66.1M | ||
| Q4 24 | $301.4M | $-6.2M | ||
| Q3 24 | $199.5M | $44.8M | ||
| Q2 24 | $279.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $28.9M | ||
| Q3 25 | $579.4M | $20.8M | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | $64.6M | ||
| Q4 24 | $176.8M | $-8.2M | ||
| Q3 24 | $88.3M | $42.5M | ||
| Q2 24 | $213.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 3.8% | ||
| Q3 25 | 47.9% | 2.8% | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | 9.2% | ||
| Q4 24 | 15.9% | -1.1% | ||
| Q3 24 | 8.9% | 5.5% | ||
| Q2 24 | 21.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.3% | ||
| Q3 25 | 6.7% | 0.3% | ||
| Q2 25 | 8.1% | 0.3% | ||
| Q1 25 | 8.4% | 0.2% | ||
| Q4 24 | 11.2% | 0.3% | ||
| Q3 24 | 11.2% | 0.3% | ||
| Q2 24 | 6.6% | 0.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.87× | ||
| Q3 25 | 2.33× | 1.17× | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | 3.79× | ||
| Q4 24 | 1.99× | -0.36× | ||
| Q3 24 | 1.48× | 2.64× | ||
| Q2 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
